Previous studies have also shown the correlation between B cells and SS disease, demonstrating lower levels of the B-cell activating factor (BAFF) in the salivary glands of SS mice treated with MSCs, indicating that MSCs confer their therapeutic effects through the attenuations of B cells in the lymphocytic infiltrates [26,27]. Here, TNFSF13B is linked to synovial sarcoma.